MSMaria Pantoja Moreira de Sena

Maria Pantoja Moreira de Sena

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria Pantoja Moreira de Sena has a total of 84 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    DEVELOPMENT AND CONTENT VALIDATION OF A MOBILE APPLICATION FOR CLINICAL ASSESSMENT AND DIABETIC FOOT PREVENTION IN PRIMARY HEALTH CARE

    by Tatiana Cristina Dias de Oliveira, Laila de Castro Araújo, Valéria de Castro Fagundes, Alana Ferreira de Oliveira, Maria Pantoja Moreira de Sena, Luann Wendel Pereira de Sena

    Diabetic foot is one of the most severe chronic complications of type 2 diabetes mellitus and is associated with high rates of ulceration, amputation, hospitalization, and mortality. Early identification of risk factors and systematic clinical foot assessment are essential strategies for preventing these complications, particularly in the context of Primary Health Care. This study aimed to develop and validate a mobile application for clinical assessment, risk stratification, and prevention of foot lesions in individuals with type 2 diabetes mellitus receiving care in Primary Health Care settings. This methodological study focused on the development and validation of a health technology and was conducted between August 2024 and August 2026. The application was developed based on scientific evidence and national and international clinical guidelines and subsequently submitted to content validation by a panel of 34 healthcare professionals experienced in diabetes care. The tool was organized into three integrated modules: user profile, clinical assessment and risk stratification, and multidisciplinary intervention and health education. Experts demonstrated a high level of agreement across all evaluated criteria, with no inadequate ratings recorded. The highest levels of agreement were observed for items related to the relevance of the application for healthcare practice (97.1%). Content Validity Index values ranged from 0.84 to 1.00, while the overall Content Validity Coefficient was 0.86, confirming satisfactory content validity. Following refinement, improvements related to usability, social determinants of health, user monitoring, and offline functionality were incorporated. The application demonstrated satisfactory evidence of content validity and potential to support clinical assessment, risk stratification, and diabetic foot prevention in Primary Health Care, representing an innovative tool for improving healthcare quality and supporting clinical decision-making within the Brazilian Unified Health System.

  • Open Access

    Medication Adherence and Its Discordance with Glycemic Control in Type 2 Diabetes: A Real-World Study in Primary Health Care in the Brazilian Amazon

    by Laila de Castro Araújo, Valéria dos Santos Lourenço, Valéria de Castro Fagundes, Alana Ferreira de Oliveira, Ana Cristina Lo Prete, Carolina Heitmann Mares Azevedo Ribeiro, Érica dos Santos Sarges, Luana Pereira Margalho, Phelipe Augusto Rabelo Paixão, Stefani Gisele Bastos Dornas, et al.

    Background/Objectives: Medication adherence is a critical determinant of therapeutic outcomes in type 2 diabetes mellitus (T2DM); however, its relationship with glycemic control remains inconsistent, particularly in real-world and socially vulnerable settings. This study aimed to evaluate medication adherence using multiple validated instruments, assess disease-related knowledge, and examine their relationship with glycemic control, with a focus on potential discordance between self-reported adherence and objective metabolic outcomes. Methods: A cross-sectional analytical study was conducted with 237 adults with T2DM receiving care in a primary health care (PHC) unit in the Brazilian Amazon. Medication adherence was assessed using the Almeida Adherence Scale, ARMS-12, and the Haynes–Sackett test, while disease-related knowledge was evaluated using the Batalla–Martínez questionnaire. Glycemic control was determined based on glycated hemoglobin (HbA1c) values obtained from clinical records within the previous three months. Descriptive and comparative analyses were performed. Results: The study population was predominantly female (64.1%) and aged 40–59 years (55.7%), with a high prevalence of socioeconomic vulnerability. Non-adherence was identified in 55.7% of participants using the Almeida Adherence Scale, whereas higher adherence rates were observed with ARMS-12 (91.1%) and the Haynes–Sackett test (72.2%). Inadequate disease-related knowledge was found in 77.2% of participants. Among individuals with available HbA1c data (n = 116), the mean HbA1c was 8.63% (SD = 1.65), and 81.9% presented inadequate glycemic control (HbA1c ≥ 7%). Notably, among participants classified as adherent by the ARMS-12 scale (91.1%), inadequate glycemic control was nonetheless present in 81.9% of those with available HbA1c data, illustrating the magnitude of the observed discordance between self-reported adherence and objective metabolic outcomes. Cross-tabulation of each adherence instrument against glycemic control showed no statistically significant associations (chi-square with Yates correction; ARMS-12: p = 0.631, φ = 0.045; Almeida Adherence Scale: p = 0.301, φ = 0.096; Haynes–Sackett: p = 0.800, φ = 0.024). Multivariable logistic regression (Nagelkerke R2 = 0.321; AUC = 0.834) identified older age (aOR = 0.92; 95% CI: 0.87–0.96; p < 0.001) and higher income (aOR = 9.96; 95% CI: 2.05–48.32; p = 0.004) as independent predictors of glycemic outcome, while no adherence measure was independently associated with HbA1c ≥ 7%. A sensitivity analysis using HbA1c ≥ 8.0% revealed poor control in 59.5% of participants (n = 69/116). Conclusions: Despite varying levels of self-reported medication adherence, inadequate glycemic control was highly prevalent. The absence of statistically significant associations between self-reported adherence and HbA1c, combined with the high prevalence of poor glycemic control regardless of adherence status, is consistent with the hypothesis that adherence alone does not fully explain metabolic outcomes in T2DM. Given the cross-sectional design, no causal inferences can be drawn. These findings highlight the need for integrated care strategies in primary health care, including improved health literacy, structured pharmacotherapeutic follow-up, and the use of multiple adherence assessment tools to better inform clinical decision-making.


  • Open Access

    Pharmacoepidemiological profile of patients treated at a teaching clinic in the brazilian Amazon

    by Leticia Rafaela Batista Contente, Leilane da Silva Leite, Erick Felipe da Silva Lucas, Joseane Rodrigues Da Silva, Luann Wendel Pereira De Sena, Maria Pantoja Moreira Sena, Auriekson Noronha Queiroz

    Characterizing medication use constitutes a fundamental health indicator, particularly in the context of challenges such as polypharmacy and self-medication. However, populations assisted in teaching clinics remain underinvestigated, despite encompassing diverse profiles and serving as strategic settings for professional training. This study aimed to characterize the therapeutic profile and health-related behaviors of patients treated at a teaching clinic in the Brazilian Amazon. An observational, cross-sectional study was conducted from october 2024 to march 2025 at the Teaching Clinic of the Universidade da Amazônia, Belém, PA, Brazil. A convenience sample included 80 consecutive adults who met the eligibility criteria. Data were collected using a semi-structured questionnaire administered through individual interviews and analyzed using descriptive statistics and chi-square/Fisher’s exact tests. The sample was predominantly female (68.7%), with a mean age of 52.13 ± 17.91 years, and 56.2% reported chronic diseases. A high prevalence of self-medication (60%) and polypharmacy (38.75%) was observed. Self-medication was significantly associated with the presence of chronic diseases (RR = 1.64; p = 0.04) and self-reported adverse drug reactions (RR = 1.93; p = 0.038). No participant demonstrated high therapeutic adherence, with neglect of dosing schedules being the main reason for non-adherence (83.75%). Access to pharmaceutical consultations was low (22.5%), and improper disposal of medications was prevalent (73.75% disposed of medicines in household waste). Integrative and Complementary Practices were used by 57.5% of participants, predominantly phytotherapy (73.9%), without professional guidance. These findings indicate a high-risk pharmacotherapeutic profile characterized by self-medication, polypharmacy, adverse drug reactions, and absence of high therapeutic adherence, associated with limited access to pharmaceutical services. The implementation of pharmaceutical care strategies integrated into the teaching-clinic environment is necessary to optimize pharmacotherapy and enhance evidence-based professional training grounded in local realities.

  • Open Access

    Perfil farmacoepidemiológico de pacientes atendidos em clínica escola na Amazônia brasileira

    by Leticia Rafaela Batista Contente, Leilane da Silva Leite, Erick Felipe da Silva Lucas, Joseane Rodrigues Da Silva, Luann Wendel Pereira De Sena, Maria Pantoja Moreira Sena, Auriekson Noronha Queiroz

    A caracterização do uso de medicamentos constitui indicador sanitário fundamental, especialmente diante de desafios como polifarmácia e automedicação. Entretanto, populações atendidas em clínicas-escola permanecem pouco investigadas, apesar de concentrarem perfis diversos e funcionarem como campo estratégico de formação profissional. Este estudo objetivou caracterizar o perfil terapêutico e comportamentos em saúde de pacientes atendidos em clínica-escola na Amazônia brasileira. Estudo observacional e transversal, realizado de outubro de 2024 a março de 2025 na Clínica-Escola da Universidade da Amazônia, Belém-PA. Amostra de conveniência incluiu 80 adultos consecutivos que atenderam aos critérios de elegibilidade. Os dados foram coletados mediante questionário semiestruturado aplicado em entrevista individual e analisados mediante estatística descritiva e testes qui-quadrado/Fisher. A amostra foi predominantemente feminina (68,7%), com idade média de 52,13±17,91 anos e 56,2% com doenças crônicas. Observou-se elevada prevalência de automedicação (60%) e polifarmácia (38,75%). A automedicação associou-se significativamente à presença de doenças crônicas (RR=1,64; p=0,04) e reações adversas autorreferidas (RR=1,93; p=0,038). Nenhum participante apresentou alta adesão terapêutica, sendo descuido com horários o principal motivo de não adesão (83,75%). O acesso à consulta farmacêutica foi baixo (22,5%) e o descarte inadequado de medicamentos prevalente (73,75% no lixo comum). Práticas Integrativas e Complementares foram utilizadas por 57,5% dos participantes, predominando fitoterapia (73,9%) sem orientação profissional. Os achados evidenciam perfil de alto risco farmacoterapêutico caracterizado por automedicação, polifarmácia, reações adversas e ausência de alta adesão terapêutica, associados ao acesso limitado aos serviços farmacêuticos. É necessário implementar estratégias de cuidado farmacêutico integradas ao ambiente clínico-escola, visando otimizar a farmacoterapia e aprimorar a formação profissional baseada em evidências locais.

  • Open Access

    Temporal trends and regional heterogeneity of leprosy in an Amazonian Brazilian state: Tocantins, 2014–2024

    by P. A. Mendonça-Cavalcante, A. P. Simões-Castro, C. Andrade-Sales, M. P. Moreira-Sena, J. L. Fernandes-Vieira, L. W. Pereira-Sena

    Leprosy remains a persistent public health challenge in Brazil, particularly in the Legal Amazon, where its distribution reflects social inequities, environmental vulnerabilities, and heterogeneous access to health services. This study analyzed the sociodemographic profile, temporal trends, and regional heterogeneity of leprosy in the state of Tocantins between 2014 and 2024. A total of 15,734 confirmed cases were obtained from the Brazilian national surveillance system. Annual detection rates and temporal trends were assessed using log-linear regression models to estimate the Annual Percent Change, and regional heterogeneity was examined across the eight health regions of the state. The disease predominantly affected men, adults aged 30–59 years, individuals with low educational attainment, and persons self-identified as of mixed race. Despite year-to-year fluctuations, including a marked decline during the COVID-19 pandemic, detection rates remained consistently high throughout the study period. Substantial heterogeneity was observed across health regions, with persistently high detection rates in Capim Dourado, Amor Perfeito, and Cantão, while statistically significant decreasing trends were identified in Bico do Papagaio, Médio Norte Araguaia, and Ilha do Bananal. The continuous detection of cases among individuals under 15 years of age and the increase in relapse proportions in recent years indicate ongoing transmission and operational challenges in early diagnosis and surveillance. These findings highlight the need for regionally tailored strategies, strengthened contact tracing, and prioritization of high-risk territories to advance leprosy control in the Brazilian Amazon.

  • Open Access

    Association between polypharmacy, medication adherence, and quality of life in patients with chronic kidney disease: a preliminary study in the Brazilian Amazon

    by Jaqueline da Trindade Valente, Maria Pantoja Moreira de Sena, Carolina Heitmann Mares Azevedo Ribeiro, José Luiz Fernandes Vieira, Luann Wendel Pereira de Sena

    Chronic kidney disease (CKD) is a progressive condition that requires complex pharmacological management, with polypharmacy being highly prevalent and potentially compromising treatment adherence and quality of life. This cross-sectional study included 52 patients with CKD treated at a regional hospital in northern Brazil. Its objective was to examine the association between polypharmacy, treatment adherence, and quality of life. Adherence was assessed using the Morisky-Green Test, while quality of life was measured with the abbreviated version of the WHOQOL-BREF instrument. Results demonstrated that 65% of patients presented moderate adherence, while 35% exhibited low adherence, which was significantly associated with lower quality-of-life scores, particularly in the physical and psychological domains. Female sex, higher educational level, and recent diagnosis (1–3 years) were predictors of better adherence. Statistical analyses included chi-square tests and logistic regression, with a 5% significance level and adjustments for sociodemographic variables. These findings reinforce the negative impact of low adherence to pharmacotherapy on the quality of life of patients with CKD and highlight the importance of targeted interventions, including individualized pharmacotherapy review, health education programs, and psychosocial support, to improve adherence and promote patient well-being.

  • Open Access

    Associação entre polifarmácia, adesão à farmacoterapia e qualidade de vida em pacientes com doença renal crônica: um estudo preliminar na Amazônia Brasileira

    by Jaqueline da Trindade Valente, Maria Pantoja Moreira de Sena, Carolina Heitmann Mares Azevedo Ribeiro, José Luiz Fernandes Vieira, Luann Wendel Pereira de Sena

    A doença renal crônica é uma condição progressiva que requer manejo farmacológico complexo, sendo a polifarmácia altamente prevalente e potencialmente comprometedora da adesão ao tratamento e da qualidade de vida. Este estudo transversal incluiu 52 pacientes com doença renal crônica atendidos em hospital regional no norte do Brasil. Seu objetivo foi examinar a associação entre polifarmácia, adesão ao tratamento e qualidade de vida. A adesão foi avaliada por meio do Teste de Morisky-Green, enquanto a qualidade de vida foi mensurada com a versão abreviada do instrumento WHOQOL-BREF. Os resultados demonstraram que 65% dos pacientes apresentaram adesão moderada, enquanto 35% exibiram baixa adesão, a qual esteve significativamente associada a escores mais baixos de qualidade de vida, especialmente nos domínios físico e psicológico. Sexo feminino, maior nível de escolaridade e tempo recente de diagnóstico (1 a 3 anos) foram preditores de melhor adesão. As análises estatísticas incluíram testes do qui-quadrado e regressão logística, com nível de significância de 5% e ajustes para variáveis sociodemográficas. Esses achados reforçam o impacto negativo da baixa adesão à farmacoterapia sobre a qualidade de vida de pacientes com doença renal crônica e destacam a importância de intervenções direcionadas, incluindo revisão individualizada da farmacoterapia, programas de educação em saúde e apoio psicossocial, para melhorar a adesão e promover o bem-estar dos pacientes.


  • “Vamos Combater a Malária”: desenvolvimento de um jogo de tabuleiro para ensino de ciências e educação em saúde

    by Ana Paula Simões Castro, Bruna Silva de Castro, Patrícia Alves de Mendonça Cavalcante, Clarisse Andrade Sales, Amanda Gabryelle Nunes Cardoso Mello, Maria Pantoja Moreira de Sena, Luann Wendel Pereira de Sena

    A Malária permanece como uma das principais doenças tropicais negligenciadas, responsável por 249 milhões de casos e 608 mil mortes no mundo em 2022, sendo que mais de 99% dos casos brasileiros concentram-se na Amazônia Legal. Apesar de sua relevância, a doença ainda recebe pouca atenção nos materiais didáticos utilizados nas escolas, especialmente da região amazônica. Este estudo descreve o desenvolvimento do jogo de tabuleiro “Vamos Combater a Malária”, elaborado como recurso educacional lúdico e de baixo custo para apoiar o ensino de ciências e a educação em saúde. O jogo foi construído com base em revisão documental e bibliográfica, utilizando relatórios da World Health Organization, publicações do Ministério da Saúde e artigos científicos recentes sobre educação em saúde e jogos didáticos. A estrutura do jogo inclui um tabuleiro com 18 casas, cartas com 20 perguntas sobre agente etiológico, sintomas, diagnóstico, prevenção, tratamento e marcos históricos da malária, além de peões, dado e gabarito de respostas. A dinâmica associa atitudes preventivas a avanços e comportamentos de risco a retrocessos, favorecendo o engajamento e o debate conceitual. Embora ainda não tenha sido testado com estudantes, foi elaborado um plano de avaliação com instrumentos cognitivos, afetivos e comportamentais para futuras aplicações. O jogo apresenta potencial como estratégia pedagógica para promover o letramento em saúde e sensibilizar estudantes sobre a prevenção da malária na Amazônia.

  • Open Access

    Digital Health Technologies for Diabetic Foot Ulcers: A Systematic Review of Clinical Evidence, Access Inequities, and Public Health Integration

    by Tatiana Cristina Dias de Oliveira, Alana Ferreira de Oliveira, Laila de Castro Araújo, Maria Pantoja Moreira de Sena, Valéria de Castro Fagundes, Phelipe Augusto Rabelo Paixão, Stefani Gisele Bastos Dornas, Clarisse Andrade Sales, Ana Paula Simões Castro, Patricia Alves de Mendonça Cavalcante, et al.

    Diabetic foot ulcers are among the most severe complications of diabetes mellitus, disproportionately affecting populations in low- and middle-income countries. Digital health technologies have emerged as promising tools for prevention, diagnosis, and management; however, their effectiveness, usability, and applicability within public health systems remain insufficiently defined. This systematic review aimed to critically synthesize the clinical effectiveness, perceived usability, and methodological quality of digital interventions for the care of individuals with diabetes-related foot ulcers. A comprehensive search was performed in PubMed, Scopus, Web of Science, Embase, and Google Scholar for studies published between 2012 and 2024. Eighteen studies met the inclusion criteria, encompassing mobile health applications, wearable sensor devices, artificial intelligence-based tools, and telehealth platforms. Methodological quality was assessed using the Mixed Methods Appraisal Tool. Artificial intelligence-driven approaches demonstrated high diagnostic accuracy, with sensitivity and specificity above 90% for ulcer detection and classification. Mobile applications showed positive effects on self-efficacy, glycemic control, and adherence to preventive foot care, while usability scores were consistently high. Wearable sensor devices demonstrated potential for reducing ulcer recurrence, though supporting evidence remains limited. Across studies, recurrent methodological limitations included small sample sizes, absence of control groups, lack of economic evaluations, and barriers related to digital literacy and interoperability between systems. Most investigations were conducted in high-income countries, with limited consideration of public health contexts such as the Brazilian Unified Health System. In conclusion, digital health technologies show promise in improving the care of individuals with diabetes-related foot complications but face significant challenges regarding scalability, equity of access, and integration into public healthcare systems. Future research should prioritize context-adapted designs, robust clinical trials, and economic evaluations to inform health policies and support the rational adoption of these tools within universal health coverage frameworks. PROSPERO registration number: CRD420251023152.


  • Open Access

    Análise situacional dos processos aquisitivos de medicamentos na Secretaria de Saúde de Belém-PA - SESMA (2019-2022): desafios e perspectivas sob a Lei nº 14.133/2021

    by Sandra Maria Pires Macedo, José Eduardo Gomes Arruda, Juan Gonzlao Bardález Rivera, Maria Pantoja Moreira de Sena, Flávia Letícia Silva Moraes, Larissa Lage de Almeida, Brenda Caroline de Lima Batista, Danielle Saraiva Tuma dos Reis

    O presente estudo teve como objetivo analisar a situação dos processos aquisitivos de medicamentos realizados pela Secretaria Municipal de Saúde de Belém (SESMA), no período de 2019 a 2022, à luz da Lei nº 14.133/2021. A aquisição de medicamentos é uma das diretrizes da Política Nacional da Assistência Farmacêutica, que desempenha uma atividade voltada para a promoção, proteção e recuperação da saúde. Evitar rupturas no processo de licitação é necessário para que o abastecimento tenha sucesso.Trata-se de uma pesquisa exploratória e quantitativa, com abordagem descritiva. A pesquisa examinou dados secundários relativos aos trâmites licitatórios, com foco nos prazos de homologação, Atas e contratose emissão das notas de empenho. Foram analisados 20 processos, destes 16 percorreram normalmente as etapas administrativas previstas para as aquisições públicas, quatro (4) foram classificados como “desertos e fracassados” por terem alguns itens licitados não adjudicados, o que demandou a instauração de novos processos.Os resultados apontaram desafios como atrasos na homologação das Atas de Registro de Preços e na emissão dos empenhos, refletindo impactos na oferta regular de medicamentos. Assim é fundamental programar ações estratégicas que garantam o acesso continuo da população aos medicamentos essenciais. Os dados reforçam ainda, a necessidade de maior planejamento e adequação dos processos administrativos à nova legislação.